课题基金 / 基金详情

Study of occurrence, proliferation and development of oral carcinomas -Exploration of abnormal cyclin-related and tumor suppresor genes-

Study of occurrence, proliferation and development of oral carcinomas -Exploration of abnormal cyclin-related and tumor suppresor genes-
口腔癌发生、增殖和发展的研究-细胞周期蛋白相关及抑癌基因异常的探索-
批准号:
09470456
负责人:
ISHIKAWA Takenori
金额:
$8.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 2000

项目摘要

项目成果

ISHIKAWA Takenori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Malignant-changing process of oral leukoplakia might surely demand hypoexpression of p14ARF and further abnormal occurrence of p53-ARF pathway. In case of oral SCC, it was suggested that expression of mutant p53, hypoexpression of p14ARF, p16 loss, hyperexpression of Cyclin D, phospholization of Rb, complete deficit of FHIT etc will be strongly correlated to the occurrence, infiltration and development of oral SCC.Furthermore, osteopontin might produce a possibility of distant metastasis by combination with CD44. In salivary gland tumors, it was supposed that p53, p21, Cyclin E and D showed different tendency in proliferation mechanism of general epithelia and myoepithelia of salivary gland. Between SCC and adenocarcinoma, arising from salivary gland and stomach, there were clearly guessed differences in the related pathologic conditions. In case of B-cell Hodgikin's lymphoma (NHL), p53 expression surely showed correlation between chemotherapy and its effect, resulting in becoming possible marker for prognosis.From above experimental results, both of two pathways of p53 and Rb may correlate occurrence and proliferation of oral cancers, based on different histologic types and connected conditions.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Ue T,: "Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis"J.Oral Pathol.and Med.. 27. 197-201 (1998)
Ue T,:“口腔鳞状细胞癌中 CD44 变异外显子的表达降低及其与转移的关系”J. Oral Pathol. and Med. 27. 197-201 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ue T: "Co-expression of Osteopontin and CD44v9 in gastric cancer"Int.J.cancer. 79. 127-132 (1998)
Ue T:“骨桥蛋白和 CD44v9 在胃癌中的共表达”Int.J.cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miwa Miyauti,etc: "P53,bcl-2 and bax abnormalities in non-Hodgkin's lymphomas of the head and neck"J Oral Pathol Med. 29. 180-185 (1999)
Miwa Miyauti等:“头颈部非霍奇金淋巴瘤中的P53、bcl-2和bax异常”J Oral Pathol Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Miwa Miyauchi: "P53, bcl-2 and bax abnormalities in non-Hodgkin's lynphomas of the head and neck"J.Oral Pathol.and Med.. 29. 180-185 (1999)
Miwa Miyauchi:“头颈非霍奇金淋巴瘤中的 P53、bcl-2 和 bax 异常”J.Oral Pathol.and Med.. 29. 180-185 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    In vitro regeneration ability and functioning differantiation of ciliated epithelial cells in odontogenic maxillary lesions
    • 批准号:
      04454502
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.48万
    • 财政年份:
      1992
    • 负责人:
      ISHIKAWA Takenori
    • 依托单位:
    国内基金
    海外基金
    软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
    • 批准号:
      2026JJ60602
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周典
    • 依托单位:
    LincRNA-p21通过p21及p53通路调控细胞增殖与凋亡参与PAH肺血管重构的分子机制研究
    • 批准号:
      2025A01015
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李泽荣
    • 依托单位:
    APEX1调控p53/p21信号通路通过缓解软骨细胞衰老延缓创伤性骨关节炎的机制研究
    • 批准号:
      2025JJ80999
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      何春荣
    • 依托单位:
    通过Sp1/HDAC1/p21途径探索结直肠癌细胞增殖的机制研究
    • 批准号:
      2025JJ70237
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      姜小叶
    • 依托单位: